Opinion

Video

What to Expect from Treatment

Author(s):

Yuliya P.L Linhares, MD,Josie Montegaard, MSN, AGPCNP-BC

Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Dr. Wenxin (Vincent) Xu
Picture of Dr. Jacob Sands
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Related Content
ctDNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma: © vitanovski - stock.adobe.com.
August 23rd 2025

DNA Test Outperforms PET/CT Scans When Detecting Lymphoma

Spencer Feldman
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
August 23rd 2025

A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

Alex Biese Brielle Benyon
Among patients with CLL, immunoglobulin replacement therapy is not associated with a reduced risk of serious infections: © stock.adobe.com.
August 23rd 2025

Immunoglobulin Replacement Not Associated With Fewer Infections in CLL

Alex Biese
CURE Talks Cancer podcast
August 23rd 2025

The Treatment Journey of a Patient with CLL

Kristie L. Kahl
Image of blood cells.
August 23rd 2025

Venclexta Treatment Combo is Being Reviewed by FDA For CLL

Ryan Scott
Jaypirca led to better response rates than Imbruvica in some previously treated patients with CLL/SLL: © stock.adobe.com.
August 23rd 2025

Jaypirca Shows Improvements Over Imbruvica in CLL/SLL

Spencer Feldman